Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.54
+0.32 (2.62%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $730.17 million as of November 22, 2024. Its market cap has increased by 73.29% in one year.
Market Cap
730.17M
Enterprise Value
154.54M
1-Year Change
73.29%
Ranking
Category
Stock Price
$12.54
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $730.17M, a decrease of -11.97%. That is a compound annual growth rate of -3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 732.50M | 68.03% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 773.26M |
| Bioventus | 754.67M |
| Anavex Life Sciences | 744.08M |
| CARGO Therapeutics | 743.35M |
| agilon health | 741.92M |
| Orthofix Medical | 716.13M |
| Tectonic Therapeutic | 687.92M |
| Definitive Healthcare | 687.83M |